Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) CFO Richard Buchholz sold 15,000 shares of Inspire Medical Systems stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $230.03, for a total transaction of $3,450,450.00. Following the completion of the transaction, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at approximately $6,503,178.13. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Inspire Medical Systems Trading Down 1.0 %
Shares of NYSE:INSP opened at $241.12 on Friday. Inspire Medical Systems, Inc. has a twelve month low of $123.27 and a twelve month high of $330.00. The company has a 50-day moving average price of $202.84 and a two-hundred day moving average price of $183.76.
Inspire Medical Systems (NYSE:INSP – Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.53. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The firm had revenue of $192.51 million for the quarter, compared to the consensus estimate of $186.75 million. During the same period last year, the firm posted $0.10 earnings per share. The business’s revenue was up 39.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.
Analysts Set New Price Targets
Check Out Our Latest Report on Inspire Medical Systems
Hedge Funds Weigh In On Inspire Medical Systems
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of Inspire Medical Systems by 130.1% in the 3rd quarter. FMR LLC now owns 2,471,464 shares of the company’s stock worth $490,437,000 after purchasing an additional 1,397,510 shares during the last quarter. Baillie Gifford & Co. raised its position in Inspire Medical Systems by 6,846.9% in the 4th quarter. Baillie Gifford & Co. now owns 1,229,879 shares of the company’s stock worth $250,194,000 after buying an additional 1,212,175 shares during the last quarter. Wellington Management Group LLP raised its position in Inspire Medical Systems by 46.4% in the 4th quarter. Wellington Management Group LLP now owns 1,430,266 shares of the company’s stock worth $290,959,000 after buying an additional 453,294 shares during the last quarter. Frontier Capital Management Co. LLC grew its stake in shares of Inspire Medical Systems by 105.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 742,046 shares of the company’s stock valued at $150,954,000 after purchasing an additional 380,362 shares during the period. Finally, Jennison Associates LLC grew its stake in shares of Inspire Medical Systems by 648.2% during the 4th quarter. Jennison Associates LLC now owns 304,886 shares of the company’s stock valued at $62,023,000 after purchasing an additional 264,139 shares during the period. Hedge funds and other institutional investors own 94.91% of the company’s stock.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Further Reading
- Five stocks we like better than Inspire Medical Systems
- 3 Best Fintech Stocks for a Portfolio Boost
- Comprehensive PepsiCo Stock Analysis
- Energy and Oil Stocks Explained
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Insider Trades May Not Tell You What You Think
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.